Related Experiment Video
Updated: Jul 16, 2026
06:11
Laparoscopic Anatomical Resection of the Right Anterior Lobe Based on the Laennec Capsule Technique
Published on: May 2, 2025
Hepatocellular carcinoma presenting as nervous system involvement.
1Department of Neurology, Chang Gung Memorial Hospital-Kaohsiung Medical Center, Chang Gung University College of Medicine, Kaoshiung, Taiwan.
European Journal of Neurology
|March 29, 2007
Summary
Hepatocellular carcinoma (HCC) rarely presents with initial nervous system symptoms. Diagnosis requires imaging and lab tests, and prognosis for HCC with nervous system involvement is poor.
Area of Science:
- Hepatology
- Neurology
- Oncology
Background:
- Hepatocellular carcinoma (HCC) is a primary liver cancer.
- Nervous system involvement in HCC is uncommon.
- Initial presentation of HCC with neurological symptoms is rare.
Purpose of the Study:
- To analyze the clinical features of HCC with initial nervous system presentation.
- To compare these cases with HCC patients who developed nervous system involvement later.
- To understand the diagnostic challenges and prognosis.
Main Methods:
- Retrospective analysis of 15,008 HCC patients over 11 years.
- Identification of 42 cases with nervous system involvement.
- Detailed analysis of 6 cases with initial neurological presentation.
Main Results:
- Only 0.04% of HCC patients presented initially with nervous system involvement.
- Common neurological symptoms included back pain, headache, and visual disturbances.
- Associated conditions included hepatitis B/C, liver cirrhosis, and portal vein thrombosis.
- Prognosis was grave, with all 6 patients dying within 9 months.
Conclusions:
- Nervous system involvement as initial presentation of HCC is rare but serious.
- Diagnosis requires a combination of imaging, histopathology, and serum alpha-fetoprotein.
- Emphasize HCC screening in endemic areas with obscure metastatic lesions.
Related Concept Videos
01:29Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
01:21Hepatic Portal System
The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is responsible...
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is responsible...
01:26Cushing Syndrome I: Introduction
Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
01:19Cushing Syndrome II: Pathophysiology
Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
01:21Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
01:28Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...